Search results
Targa Resources beats first-quarter core profit estimates on higher transportation volumes
Reuters via Yahoo Finance· 1 hour agoTarga Resources beat Wall Street estimates for first-quarter core profit, as the pipeline operator benefitted from higher volumes of natural gas liquids (NGL) transported ...
DOJ sides with Native American tribe in lawsuit against major oil company: 'Lacks any legal right to...
The Cool Down via Yahoo News· 22 hours agoCanadian oil company Enbridge owns a pipeline that runs across Wisconsin and Michigan. After years...
Earnings call: Jazz Pharmaceuticals sustains growth with key drivers By Investing.com
Investing.com· 2 hours agoThe company has completed a Biologics License Application (BLA) for zanidatamab in the treatment of...
Agios Pharmaceuticals Reports Q1 2024 Earnings: Narrower Loss than Expected with Strong Revenue ...
GuruFocus.com via Yahoo Finance· 15 minutes agoCash Position: Ended Q1 2024 with $714.3 million in cash, cash equivalents, and marketable...
Mountain Valley Pipeline hopes for May 31 commissioning as costs rise
WPXI via Yahoo Finance· 22 hours agoAfter nearly a decade of construction and court battles that went to the halls of Congress and the...
Plains All American Pipeline LP's Dividend Analysis
GuruFocus.com via Yahoo Finance· 2 days agoPlains All American Pipeline LP (NASDAQ:PAA) recently announced a dividend of $0.32 per share, payable on 2024-05-15, with the ex-dividend date set for...
Decoding DuPont de Nemours Inc (DD): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 8 hours agoNet sales show a slight decrease, reflecting challenging market conditions. Strong brand portfolio...
Trans Mountain opens 'pretty vast market,' says Cenovus — but it's likely Canada's last pipeline
Financial Post via Yahoo Finance· 18 hours agoCenovus Energy Inc. has its eyes set on a “pretty vast market” as it gets set to make the most of...
Novartis to buy radiology drug specialist Mariana for $1 billion
Reuters via AOL· 2 hours agoMariana Oncology is working on novel radioligand cancer therapies (RLTs) that have not yet been...
Blueprint Medicines Corp Reports Q1 2024 Earnings, Surpasses Revenue Estimates and Raises ...
GuruFocus.com via Yahoo Finance· 23 minutes agoThe company's leading product, AYVAKIT, is designed for the treatment of systemic mastocytosis, and it has a diverse pipeline including BLU-808 for various mast cell disorders ...